HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of CRH and its inhibitor, antalarmin, on in vitro growth of preantral mouse follicles, early embryo development, and steroidogenesis.

Abstract
In vitro growth systems of preantral follicles allow studying the effect of various endocrine, paracrine, and autocrine factors on follicular growth and oocyte maturation. CRH is a 41-amino-acid neuropeptide responsible for endocrine, autonomic, immunological, and behavioral responses of mammals to stress and has two receptors, CRH receptor type 1 (CRH-R1) and CRH-R2. Antalarmin, a CRH-R1 antagonist, has been used to elucidate the role of CRH in stress, inflammation, and reproduction. The present study describes in vitro growth of mouse preantral follicles, early embryo development, and steroidogenesis in the presence of CRH and its antagonist antalarmin. We cultured 732 follicles in control media, 1306 in CRH 10(-7) mol/liter, and 1202 in CRH 10(-7) plus antalarmin 10(-6) mol/liter. The culture medium was assayed on alternate days for 17β-estradiol, progesterone, and β-human chorionic gonadotropin. Total RNA was extracted from preantral follicles as well as early preimplantation embryos and was assessed by real-time RT-PCR for the expression of CRH-R1 and CRH-R2 mRNAs. Hormone analysis showed that the CRH group had lower levels of 17β-estradiol, progesterone, and β-human chorionic gonadotropin as the culture progressed, in comparison with the other two groups. RT-PCR demonstrated the presence of CRH-R1 and CRH-R2 in all stages of preantral follicle culture. Morula/blastocyst-stage embryos expressed only CRH-R1. In conclusion, CRH has an inhibitory effect on in vitro fertilized oocytes, resulting from cultured preantral follicles at all stages of preimplantation embryo development. Furthermore, the presence of CRH in the culture medium inhibits steroidogenesis by preantral mouse follicles cultured in vitro.
AuthorsV Dinopoulou, G A Partsinevelos, D Mavrogianni, E Anagnostou, P Drakakis, A Makrigiannakis, G P Chrousos, D Loutradis
JournalEndocrinology (Endocrinology) Vol. 154 Issue 1 Pg. 222-31 (Jan 2013) ISSN: 1945-7170 [Electronic] United States
PMID23211705 (Publication Type: Journal Article)
Chemical References
  • CRF receptor type 2
  • Chorionic Gonadotropin, beta Subunit, Human
  • Pyrimidines
  • Pyrroles
  • Receptors, Corticotropin-Releasing Hormone
  • antalarmin
  • Progesterone
  • Estradiol
  • CRF receptor type 1
  • Corticotropin-Releasing Hormone
Topics
  • Animals
  • Chorionic Gonadotropin, beta Subunit, Human (metabolism)
  • Corticotropin-Releasing Hormone (pharmacology)
  • Embryonic Development (drug effects, genetics)
  • Estradiol (metabolism)
  • Female
  • Male
  • Mice
  • Ovarian Follicle (drug effects)
  • Pregnancy
  • Progesterone (metabolism)
  • Pyrimidines (pharmacology)
  • Pyrroles (pharmacology)
  • Receptors, Corticotropin-Releasing Hormone (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: